A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer

PURPOSE: Addition of perioperative multi‐agent chemotherapy to the treatment strategy for locally advanced rectal cancer (LARC) may be a promising option. We conducted a phase II study to evaluate the safety and efficacy of capecitabine combined with oxaliplatin and irinotecan (XELOXIRI) as triplet...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuda, Chu, Kudo, Toshihiro, Morimoto, Yoshihiro, Kagawa, Yoshinori, Tei, Mitsuyoshi, Ide, Yoshihito, Miyoshi, Norikatsu, Takahashi, Hidekazu, Uemura, Mamoru, Takemasa, Ichiro, Satoh, Taroh, Mizushima, Tsunekazu, Murata, Kohei, Doki, Yuichiro, Eguchi, Hidetoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831889/
https://www.ncbi.nlm.nih.gov/pubmed/36643362
http://dx.doi.org/10.1002/ags3.12600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831889/
https://www.ncbi.nlm.nih.gov/pubmed/36643362
http://dx.doi.org/10.1002/ags3.12600

Ejemplares similares